Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1987;9:647-653

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, P. C.
Right arrow Articles by van Brummelen, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, P. C.
Right arrow Articles by van Brummelen, P.

Hypertension, Vol 9, 647-653, Copyright © 1987 by American Heart Association


ARTICLES

Demonstration of neuronal and extraneuronal uptake of circulating norepinephrine in the forearm

PC Chang, JA van der Krogt and P van Brummelen

Disturbances in peripheral norepinephrine release or removal by neuronal and extraneuronal uptake may have pathogenetic significance in cardiovascular disease states. We investigated the mechanisms of removal of norepinephrine in the forearm of healthy subjects under basal conditions, using measurements of arterial and venous plasma norepinephrine concentrations, blood pressure, heart rate, and forearm blood flow. The specific inhibitor of neuronal uptake, desipramine, was infused intra-arterially into the brachial artery of five subjects. Net norepinephrine overflow from the forearm increased markedly, revealing considerable local release of norepinephrine. Six other subjects received four intra-arterial infusions of norepinephrine, 1.18 pmol/kg/min, with various doses of desipramine and the extraneuronal uptake-inhibiting drug hydrocortisone. The forearm extraction rate for circulating norepinephrine decreased with increasing doses of desipramine (from 69.4 +/- 3.0 [SEM] to 35.3 +/- 8.4%; p less than 0.001). Increasing doses of hydrocortisone during continued inhibition of neuronal uptake resulted in decreased forearm extraction of norepinephrine (from 63.3 +/- 4.9 to 40.6 +/- 4.4%; p less than 0.01). In six other subjects who received the highest dose of hydrocortisone without concomitant inhibition of neuronal uptake, forearm extraction of norepinephrine decreased from 57.1 +/- 4.9 to 51.5 +/- 4.7% (p less than 0.05). These results suggest that neuronal uptake contributes markedly to the removal of circulating and endogenously released norepinephrine in the forearm. For circulating norepinephrine, a corticosteroid-sensitive mechanism of extraneuronal uptake was also demonstrated. These results indicate that neuronal and extraneuronal uptake can be estimated separately in this vascular bed. Similar organ- specific studies in patients may reveal disturbances in mechanisms of norepinephrine removal.


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
S. D. KUMAR, J. L. BRIEVA, I. DANTA, and A. WANNER
Transient Effect of Inhaled Fluticasone on Airway Mucosal Blood Flow in Subjects with and without Asthma
Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 918 - 921.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
A. Roy, D. Pickar, J. De Jong, F. Karoum, and M. Linnoila
Norepinephrine and Its Metabolites in Cerebrospinal Fluid, Plasma, and Urine: Relationship to Hypothalamic-Pituitary-Adrenal Axis Function in Depression
Arch Gen Psychiatry, September 1, 1988; 45(9): 849 - 857.
[Abstract] [PDF]